Fuller & Thaler Asset Management Inc. Purchases 52,130 Shares of Azenta, Inc. (NASDAQ:AZTA)

Fuller & Thaler Asset Management Inc. lifted its holdings in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 9.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 586,347 shares of the company's stock after acquiring an additional 52,130 shares during the period. Fuller & Thaler Asset Management Inc. owned approximately 1.28% of Azenta worth $29,317,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Dimensional Fund Advisors LP boosted its position in shares of Azenta by 0.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,033,171 shares of the company's stock worth $151,659,000 after purchasing an additional 26,929 shares in the last quarter. Conestoga Capital Advisors LLC grew its stake in Azenta by 65.0% in the fourth quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company's stock valued at $78,894,000 after acquiring an additional 621,830 shares during the period. Schroder Investment Management Group raised its position in shares of Azenta by 46.7% during the fourth quarter. Schroder Investment Management Group now owns 1,405,056 shares of the company's stock worth $70,183,000 after purchasing an additional 447,292 shares during the period. Allspring Global Investments Holdings LLC increased its stake in Azenta by 1.4% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,317,385 shares of the company's stock valued at $65,922,000 after purchasing an additional 18,529 shares in the last quarter. Finally, Federated Hermes Inc. grew its holdings in shares of Azenta by 65.9% during the fourth quarter. Federated Hermes Inc. now owns 762,189 shares of the company's stock valued at $38,109,000 after buying an additional 302,786 shares during the last quarter. Institutional investors own 99.08% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Stephens reiterated an "overweight" rating and set a $60.00 price target on shares of Azenta in a research note on Thursday, January 2nd. TD Cowen raised Azenta to a "hold" rating in a research report on Thursday, February 27th. Evercore ISI boosted their price target on shares of Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a report on Thursday, February 6th. Finally, Needham & Company LLC increased their price target on shares of Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a research report on Thursday, February 6th.

Azenta Trading Down 2.0 %

Shares of NASDAQ AZTA traded down $0.52 during midday trading on Wednesday, hitting $26.09. 175,212 shares of the company's stock were exchanged, compared to its average volume of 647,258. The business's fifty day moving average price is $34.29 and its two-hundred day moving average price is $43.00. The company has a market cap of $1.19 billion, a price-to-earnings ratio of -8.76 and a beta of 1.66. Azenta, Inc. has a 12-month low of $24.06 and a 12-month high of $63.58.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, beating analysts' consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. Equities analysts expect that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.